Abstract
Non-syndromic cleft lip with palate (NSCLP) is the most serious sub-phenotype of non-syndromic orofacial clefts (NSOFC), which are the most common craniofacial birth defects in humans. Here we conduct a GWAS of NSCLP with multiple independent replications, totalling 7,404 NSOFC cases and 16,059 controls from several ethnicities, to identify new NSCLP risk loci, and explore the genetic heterogeneity between sub-phenotypes of NSOFC. We identify 41 SNPs within 26 loci that achieve genome-wide significance, 14 of which are novel (RAD54B, TMEM19, KRT18, WNT9B, GSC/DICER1, PTCH1, RPS26, OFCC1/TFAP2A, TAF1B, FGF10, MSX1, LINC00640, FGFR1 and SPRY1). These 26 loci collectively account for 10.94% of the heritability for NSCLP in Chinese population. We find evidence of genetic heterogeneity between the sub-phenotypes of NSOFC and among different populations. This study substantially increases the number of genetic susceptibility loci for NSCLP and provides important insights into the genetic aetiology of this common craniofacial malformation.
Introduction
Orofacial clefts (OFCs) are among the most common human birth defects, with the highest prevalence observed in Asian populations. While genetics play a significant role, the full "genetic architecture" of the condition has remained incomplete. A major point of contention in the field is genetic heterogeneity: whether cleft lip only (NSCLO), cleft palate only (NSCPO), or a combination (NSCLP) are different severities of the same genetic etiology or biologically distinct conditions. This study clarifies these distinctions while identifying new susceptibility markers in a massive, multi-ethnic dataset.
Methods
The researchers employed a robust two-stage genome-wide association study (GWAS) design followed by meta-analysis and multi-ethnic replication.
Study Design
- Discovery Stage: Genotyping of over 800,000 SNPs in a cohort of ~2,000 Chinese Han cases and ~4,000 controls.
- Replication Stage: Promising markers were tested in an independent cohort of ~1,300 cases and ~4,500 controls.
- Meta-Analysis: Data from both stages were combined to reach genome-wide significance ($P < 5 \times 10^{-8}$).
Datasets
The study utilized a total of 7,404 cases and 16,059 controls across several ethnicities. Primary cohorts consisted of Chinese Han ancestry, while multi-ethnic replication included Central European, Asian, and European American populations. Specific cohorts for NSCLO and NSCPO were utilized to test for genetic heterogeneity.
Results
The meta-analysis identified 41 significant SNPs across 26 distinct loci. Notably, 14 of these loci are novel, including RAD54B, TMEM19, KRT18, WNT9B, GSC/DICER1, PTCH1, RPS26, OFCC1/TFAP2A, TAF1B, FGF10, MSX1, LINC00640, FGFR1, and SPRY1.
Biological Pathways and Heritability
The 26 identified loci collectively account for 10.94% of the heritability for NSCLP in the Chinese population. Network analysis successfully linked 24 of the 28 notable genes into a functional similarity network, highlighting key developmental "circuits":
- FGF Signaling Hub: Multiple novel loci (FGF10, FGFR1, SPRY1) converge on the Fibroblast Growth Factor pathway, suggesting its disruption is a primary driver of cleft formation.
- Ribosomopathies: Associations with genes involved in ribosome biogenesis (RPS26 and TAF1B) suggest that the basic protein-building machinery is critical for the high-precision timing required for facial development.
Genetic Heterogeneity
The data confirmed that NSCLP and NSCLO share many genetic risk factors, but NSCPO (cleft palate only) is often genetically distinct. This supports the theory that the primary and secondary palates develop through different biological programs. Additionally, the IRF6 locus showed stronger effects in males, and evidence suggested certain genetic risks might be amplified by maternal age.
Discussion
This study substantially increases the number of genetic susceptibility loci for NSCLP. However, the authors note that sample sizes for non-Chinese replication cohorts were relatively small, which may explain why some loci did not replicate across all ethnicities. Future work will focus on functional validation using CRISPR or animal models to prove exactly how mutations in enhancers near genes like FGF10 prevent palate fusion during embryonic development. Trans-ethnic meta-analyses will be required to identify universal causal variants that transcend specific populations.
Summary updated